Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Creative Medical Technology Holdings

Creative Medical Technology Holdings

Creative Medical Technology Holdings is a biotechnology company developing stem cell therapies for treating conditions related to urology and neurology.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

June 22, 2021
Creative Medical Technology Holdings announces the recruitment of Dr. Courtney Bartlett to lead clinical development of the Company's pipeline of therapeutic products.
January 19, 2021
Creative Medical Technology Holdings Announces Positive Data and Patent Filing Using ImmCelz®

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
June 22, 2021
BioSpace
Creative Medical Technology Holdings Recruits Renowned Stem Cell Clinical Trials Expert to Hyper-Accelerate FDA Clearance - read this article along with other careers information, tips and advice on BioSpace
Creative Medical Technology Holdings, Inc.
June 22, 2021
www.prnewswire.com:443
/PRNewswire/ -- (OTC-CELZ) Creative Medical Technology Holdings announced today recruitment of Dr. Courtney Bartlett to lead clinical development of the...
Creative Medical Technology Holdings, Inc.
June 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- Creative Medical Technology Holdings, trading under Ticker Symbol CELZ, announced the filing of a provisional patent application in connection...
May 24, 2021
BioSpace
Creative Medical Technology Holdings Expands Neurological Application of ImmCelz® into Parkinson's Disease - read this article along with other careers information, tips and advice on BioSpace
Creative Medical Technology Holdings, Inc.
May 24, 2021
www.prnewswire.com:443
/PRNewswire/ -- Creative Medical Technology Holdings, trading under ticker symbol CELZ, announced today positive preclinical data supporting extension of...
SHOW MORE

References

Golden logo
By using this site, you agree to our Terms & Conditions.